Zyprexa and Pancreatitis - a phase IV clinical study of FDA data

Summary:

Pancreatitis is found among people who take Zyprexa, especially for people who are female, 40-49 old, have been taking the drug for 2 - 5 years.

The phase IV clinical study analyzes which people take Zyprexa and have Pancreatitis. It is created by eHealthMe based on reports of 61,460 people who have side effects when taking Zyprexa from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Mar, 28, 2023

61,460 people reported to have side effects when taking Zyprexa.
Among them, 2,458 people (4.0%) have Pancreatitis.

What is Zyprexa?

Zyprexa has active ingredients of olanzapine. It is often used in bipolar disorder. eHealthMe is studying from 62,750 Zyprexa users for its effectiveness, alternative drugs and more.

What is Pancreatitis?

Pancreatitis (inflammation of pancreas) is found to be associated with 2,796 drugs and 1,969 conditions by eHealthMe.

Number of Zyprexa and Pancreatitis reports submitted per year:

* Approximation only. Some reports may have incomplete information.

Do you take Zyprexa and have Pancreatitis?

Check whether Pancreatitis is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related publications that referenced our studies

Sirkeci, ?., Sirkeci, E. E., & Ta?el, B. , "Rivaroxaban-induced acute pancreatitis", The European Research Journal, 2018 Jan .
Gupta SK, Shwetank B, "Reversible bilateral sensori-neural hearing loss due to olanzapine in a male suffering from bipolar affective disorder", Indian journal of pharmacology, 2014 Jan .
Liao, K. F., Huang, P. T., Lin, C. C., Lin, C. L., & Lai, S. W., "Fluvastatin use and risk of acute pancreatitis: a population-based case-control study in Taiwan", Biomedicine, 2014 Jan .
Og?odek E, Szota A, Araszkiewicz A, "Olanzapine-induced neuroleptic malignant syndrome after 10 years of treatment", Aust NZJ Psychiatry, 2013 Oct .
Arshad F, Ladakhi Y, Khan MA, "A rare case of carbamazepine induced pancreatitis", International Journal of Students’ Research, 2013 Jul .
Das S, Mondal S, Dey JK, Bandyopadhyay S, Saha I, Tripathi SK, "A case of montelukast induced hypercholesterolemia, severe hypertriglyceridemia and pancreatitis", Journal of Young Pharmacists, 2013 Jun .

Related studies

How severe was Pancreatitis and when was it recovered:

Pancreatitis in Zyprexa

Expand to all the drugs that have ingredients of olanzapine:

Pancreatitis and drugs with ingredients of olanzapine (2,616 reports)

Alternative drugs to, pros and cons of Zyprexa:

Zyprexa (62,750 reports)

Common Zyprexa side effects:

Diabetes: 6,914 reports
Weight increased: 5,992 reports
Type 2 diabetes: 3,024 reports
High blood cholesterol: 2,884 reports
High blood pressure: 2,847 reports

Browse all side effects of Zyprexa:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Pancreatitis treatments and more:

Pancreatitis (56,682 reports)

COVID vaccines that are related to Pancreatitis:

Common drugs associated with Pancreatitis:

All the drugs that are associated with Pancreatitis:

Pancreatitis (2,796 drugs)

Common conditions associated with Pancreatitis:

Type 2 diabetes: 5,528 reports
Diabetes: 3,048 reports
High blood pressure: 2,706 reports
Depression: 2,134 reports
Rheumatoid arthritis: 1,792 reports

All the conditions that are associated with Pancreatitis:

Pancreatitis (1,969 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on olanzapine (the active ingredients of Zyprexa) and Zyprexa (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.